vs

Side-by-side financial comparison of EMERSON RADIO CORP (MSN) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.9M, roughly 1.1× EMERSON RADIO CORP). EMERSON RADIO CORP runs the higher net margin — -36.7% vs -13301.2%, a 13264.5% gap on every dollar of revenue. On growth, EMERSON RADIO CORP posted the faster year-over-year revenue change (-52.8% vs -77.8%). Over the past eight quarters, EMERSON RADIO CORP's revenue compounded faster (-7.3% CAGR vs -73.7%).

Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

MSN vs ROIV — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.1× larger
ROIV
$2.0M
$1.9M
MSN
Growing faster (revenue YoY)
MSN
MSN
+25.1% gap
MSN
-52.8%
-77.8%
ROIV
Higher net margin
MSN
MSN
13264.5% more per $
MSN
-36.7%
-13301.2%
ROIV
Faster 2-yr revenue CAGR
MSN
MSN
Annualised
MSN
-7.3%
-73.7%
ROIV

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
MSN
MSN
ROIV
ROIV
Revenue
$1.9M
$2.0M
Net Profit
$-694.0K
$-265.9M
Gross Margin
10.9%
Operating Margin
-43.7%
-16966.1%
Net Margin
-36.7%
-13301.2%
Revenue YoY
-52.8%
-77.8%
Net Profit YoY
-31.7%
-257.0%
EPS (diluted)
$-0.03
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSN
MSN
ROIV
ROIV
Q4 25
$1.9M
$2.0M
Q3 25
$1.2M
$1.6M
Q2 25
$1.7M
$2.2M
Q1 25
$1.8M
$-39.6M
Q4 24
$4.0M
$9.0M
Q3 24
$2.7M
$4.5M
Q2 24
$2.2M
$8.0M
Q1 24
$2.2M
$28.9M
Net Profit
MSN
MSN
ROIV
ROIV
Q4 25
$-694.0K
$-265.9M
Q3 25
$-1.0M
$-113.5M
Q2 25
$-1.1M
$-223.4M
Q1 25
$-2.4M
$-206.5M
Q4 24
$-527.0K
$169.4M
Q3 24
$-881.0K
$-230.2M
Q2 24
$-962.0K
$95.3M
Q1 24
$-883.0K
$-151.1M
Gross Margin
MSN
MSN
ROIV
ROIV
Q4 25
10.9%
Q3 25
-0.1%
Q2 25
0.7%
Q1 25
-3.0%
Q4 24
12.3%
Q3 24
9.9%
Q2 24
8.8%
Q1 24
15.9%
Operating Margin
MSN
MSN
ROIV
ROIV
Q4 25
-43.7%
-16966.1%
Q3 25
-98.4%
-19492.9%
Q2 25
-78.1%
-13130.0%
Q1 25
-137.8%
674.8%
Q4 24
-18.3%
-3042.6%
Q3 24
-40.8%
-7636.0%
Q2 24
-55.6%
-1279.5%
Q1 24
-52.2%
-919.5%
Net Margin
MSN
MSN
ROIV
ROIV
Q4 25
-36.7%
-13301.2%
Q3 25
-85.8%
-7225.9%
Q2 25
-68.1%
-10292.9%
Q1 25
-127.9%
521.8%
Q4 24
-13.2%
1878.3%
Q3 24
-32.2%
-5143.8%
Q2 24
-43.8%
1192.7%
Q1 24
-40.1%
-522.3%
EPS (diluted)
MSN
MSN
ROIV
ROIV
Q4 25
$-0.03
$-0.38
Q3 25
$-0.05
$-0.17
Q2 25
$-0.05
$-0.33
Q1 25
$-0.10
$-0.28
Q4 24
$-0.03
$0.23
Q3 24
$-0.04
$-0.31
Q2 24
$-0.05
$0.12
Q1 24
$-0.04
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSN
MSN
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$13.3M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$18.6M
$4.3B
Total Assets
$20.1M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSN
MSN
ROIV
ROIV
Q4 25
$13.3M
$4.5B
Q3 25
$13.5M
$4.4B
Q2 25
$15.5M
$4.5B
Q1 25
$16.1M
$4.9B
Q4 24
$16.4M
$5.1B
Q3 24
$16.7M
$5.4B
Q2 24
$18.9M
$5.7B
Q1 24
$19.9M
$6.5B
Total Debt
MSN
MSN
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
MSN
MSN
ROIV
ROIV
Q4 25
$18.6M
$4.3B
Q3 25
$19.3M
$4.4B
Q2 25
$20.4M
$4.3B
Q1 25
$21.5M
$4.7B
Q4 24
$23.9M
$5.2B
Q3 24
$24.4M
$5.2B
Q2 24
$25.3M
$5.4B
Q1 24
$26.2M
$6.0B
Total Assets
MSN
MSN
ROIV
ROIV
Q4 25
$20.1M
$5.2B
Q3 25
$20.7M
$5.1B
Q2 25
$23.3M
$5.0B
Q1 25
$23.5M
$5.4B
Q4 24
$26.4M
$5.8B
Q3 24
$26.6M
$6.2B
Q2 24
$28.5M
$6.5B
Q1 24
$29.1M
$7.2B
Debt / Equity
MSN
MSN
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSN
MSN
ROIV
ROIV
Operating Cash FlowLast quarter
$-228.0K
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
0.0%
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSN
MSN
ROIV
ROIV
Q4 25
$-228.0K
$-196.5M
Q3 25
$-2.0M
$-185.7M
Q2 25
$-514.0K
$-204.4M
Q1 25
$-391.0K
$-172.6M
Q4 24
$-293.0K
$-207.3M
Q3 24
$-2.1M
$-266.8M
Q2 24
$-840.0K
$-192.8M
Q1 24
$-2.2M
$-108.5M
Free Cash Flow
MSN
MSN
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-301.0K
$-209.1M
Q3 24
$-2.1M
$-267.8M
Q2 24
$-1.0M
$-193.8M
Q1 24
$-2.3M
$-108.8M
FCF Margin
MSN
MSN
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-7.5%
-2318.5%
Q3 24
-77.8%
-5984.4%
Q2 24
-46.4%
-2425.5%
Q1 24
-102.3%
-376.1%
Capex Intensity
MSN
MSN
ROIV
ROIV
Q4 25
0.0%
246.9%
Q3 25
0.0%
499.6%
Q2 25
0.0%
185.9%
Q1 25
0.0%
-2.0%
Q4 24
0.2%
20.3%
Q3 24
0.3%
22.3%
Q2 24
8.2%
12.1%
Q1 24
0.5%
1.2%
Cash Conversion
MSN
MSN
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSN
MSN

Products$1.8M95%
Other$87.0K5%

ROIV
ROIV

Segment breakdown not available.

Related Comparisons